Top

12-01-2016 | Psoriatic arthritis | Book Chapter | Article

4. Epidemiology of Psoriasis and Psoriatic Arthritis

Authors: Rodolfo Perez-Alamino, MD, Hisham Sharlala, MRCP (Rheumatology), Ade Adebajo, FRCP, FACP, FAcMed, Luis R. Espinoza, MD

Publisher: Springer International Publishing

Abstract

Psoriatic arthritis (PsA) is a unique type of chronic inflammatory arthritis that occurs in association with the skin manifestations of psoriasis, commonly presenting with extra articular manifestations which includes nail involvement, enthesitis and dactilitis. It is also important to note that like rheumatoid arthritis PsA has been shown to have significant cardiovascular comorbidities.

Studying the epidemiology of PsA has been limited by the lack of a universally agreed classification criteria. Since the introduction of the CASPAR classification criteria, we are seeing a promising trend towards the acceptance of this criteria as an internationally agreed method for present and future epidemiological and research work in the field of PsA.

In this chapter we present the available data on the incidence and prevalence of Psoriasis, PsA and the possible associated CVD comorbidities. The data show the extent of variabilities of PsA incidence and prevalance between different ethnic and population groups. The highest reported prevalence of Psoriasis worldwide (11.8 %) came from Kazakhastan, and generally believed to be higher in populations of European ethnicity and lowest in West Africa and East Asia.

The prevalance of PsA in the general population ranged from the highest reported in Italy 0.42 % to the lowest in Japan at 0.001 %. On the other hand the prevalence of PsA in Psoriasis patients increases to the range of 6–40 %.

The incidence of reported cases of PsA is gradually increasing due to the improved awareness of the condition amongst primary care physicians.

Gladman DD, Antoni C, Mease P, et al. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64 Suppl 2:ii14–7.PubMedPubMedCentral

Cuchacovich R, Perez-Alamino R, Garcia-Valladares I, et al. Steps in the managament of psoriatic arthritis: a guide for clinicians. Ther Adv Chronic Dis. 2012;3(6):259–69.PubMedPubMedCentralCrossRef

Fox DM. Evidence of evidence-based health policy: the politics of systematic reviews in coverage decisions. Health Aff. 2005;24(1):114–22.CrossRef

Mallen C, Peat G, Croft P. Quality assessment of observational studies is not common place in systematic reviews. J Clin Epidemiol. 2006;59(8):765–9.PubMedCrossRef

Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum. 1973;3(1):55–78.PubMedCrossRef

Helliwell PS, Taylor WJ. Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis. 2005;64(2):ii3–8.PubMedPubMedCentral

Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665–73.PubMedCrossRef

Gladman D. Epidemiology. Psoriatic arthritis. In: Gordon GB, Ruderman E, editors. Psoriasis and psoriatic arthritis: an integrated approach. Heidelberg: Springer; 2005. p. 57–65.CrossRef

Gladman D, Shuckett R, Russell M, et al. Psoriatic arthritis PsA- an analysis of 220 patients. Q J Med. 1987;62:127.PubMed

10.

Torre-Alonso JC, Rodriguez-Perez A, Arribas-Castrillo JM, et al. Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients. Br J Rheumatol. 1991;30:245–50.PubMedCrossRef

11.

Boyer G, Templin D, Cornoni-Huntley J, et al. Prevalence of spondyloarthropathies in Alaskan Eskimos. J Rheumatol. 1994;21(12):2292–7.PubMed

12.

Alexeeva L, Krylov M, Vturin V, et al. Prevalence of spondyloarthropathies and HLA-B27 in the native population of Chukotka, Russia. J Rheumatol. 1994;21(12):2298–300.PubMed

13.

Braun J, Bollow M, Remlinger G, et al. Prevalence of spondylarthropathies in HLAB27 positive and negative blood donors. Arthritis Rheum. 1998;41(1):58–67.PubMedCrossRef

14.

Shbeeb M, Uramoto KM, Gibson LE, et al. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982–1991. J Rheumatol. 2000;27(5):1247–50.PubMed

15.

Taylor WJ, Marchesoni A, Arreghini M, et al. A comparison of the performance characteristics of classification criteria for the diagnosis of psoriatic arthritis. Semin Arthritis Rheum. 2004;34:575–84.PubMedCrossRef

16.

Hukuda S, Minami M, Saito T, et al. Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan Ankylosing Spondylitis Society. J Rheumatol. 2001;28(3):554–9.PubMed

17.

Saraux A, Guillemin F, Guggenbuhl P, et al. Prevalence of spondyloarthropathies in France: 2001. Ann Rheum Dis. 2005;64(10):1431–5.PubMedPubMedCentralCrossRef

18.

Trontzas P, Andrianakos A, Miyakis S, et al. Seronegative spondyloarthropathies in Greece: a population-based study of prevalence, clinical pattern, and management. The ESORDIG study. Clin Rheumatol. 2005;24(6):583–9.PubMedCrossRef

19.

Madland TM, Apalset EM, Johannessen AE, et al. Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway. J Rheumatol. 2005;32(10):1918–22.PubMed

20.

De Angelis R, Salaffi F, Grassi W. Prevalence of spondyloarthropathies in an Italian population sample: a regional community-based study. Scand J Rheumatol. 2007;36(1):14–21.PubMedCrossRef

21.

Love TJ, Gudbjornsson B, Gudjonsson JE, et al. Psoriatic arthritis in Reykjavik, Iceland: prevalence, demographics, and disease course. J Rheumatol. 2007;34(10):2082–8.PubMed

22.

Liao ZT, Pan YF, Huang JL, et al. An epidemiological survey of low back pain and axial spondyloarthritis in a Chinese Han population. Scand J Rheumatol. 2009;38(6):455–9.PubMedCrossRef

23.

Wilson FC, Icen M, Crowson CS, et al. Time trends in epidemiology and characteristics of psoriatic arthritis over 3 decades: a population-based study. J Rheumatol. 2009;36(2):361–7.PubMedPubMedCentralCrossRef

24.

Hanova P, Pavelka K, Holcatova I, et al. Incidence and prevalence of psoriatic arthritis, ankylosing spondylitis, and reactive arthritis in the first descriptive population-based study in the Czech Republic. Scand J Rheumatol. 2010;39(4):310–7.PubMedCrossRef

25.

Haglund E, Bremander AB, Petersson IF, et al. Prevalence of spondyloarthritis and its subtypes in southern Sweden. Ann Rheum Dis. 2011;70(6):943–8.PubMedCrossRef

26.

Soriano ER, Rosa J, Velozo E, et al. Incidence and prevalence of psoriatic arthritis in Buenos Aires, Argentina: a 6-year health management organization based study. Rheumatology (Oxford). 2011;50(4):729–34.CrossRef

27.

Alvarez-Nemegyei J, Pelaez-Ballestas I, Sanin LH, et al. Prevalence of Musculoskeletal pain and rheumatic diseases in the southeastern region of Mexico. A COPCORD-based community survey. J Rheumatol Suppl. 2011;86:21–5.PubMedCrossRef

28.

Zacharie H. Prevalence of joint disease in patients with psoriasis: implications for therapy. Am J Clin Dermatol. 2003;4:441.CrossRef

29.

Gelfand JM, Gladman DD, Mease PJ, et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol. 2005;53:573.PubMedCrossRef

30.

Tam LS, Leung YY, Li EK. Psoriatic arthritis in Asia. Rheumatology (Oxford). 2009;48(12):1473–7.CrossRef

31.

Yang Q, Qu L, Tian H, et al. Prevalence and characteristics of psoriatic arthritis in Chinese patients with psoriasis. J Eur Acad Dermatol Venereol. 2011;25(12):1409–14.PubMedCrossRef

32.

Alamanos Y, Voulgari PV, Drossos AA. Incidence and prevalence of psoriatic arthritis: a systematic review. J Rheumatol. 2008;35(7):1354–8.PubMed

33.

Christophers E, Barker JN, Griffiths CE, et al. The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics. J Eur Acad Dermatol Venereol. 2010;24:548.PubMedCrossRef

34.

Reich K, Kruger K, Mossner R, et al. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol. 2009;160:1040.PubMedCrossRef

35.

Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum. 2009;61:1373.PubMedCrossRef

36.

Kane D, Stafford L, Bresnihan B, et al. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford). 2003;42:1460.CrossRef

37.

Haroon M, Kirby B, Fitzgerald O. High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. Ann Rheum Dis. 2013;72(5):736–40.PubMedCrossRef

38.

Maldonado-Ficco H, Citera G, Maldonado-Cocco JA. Prevalence of psoriatic arthritis in psoriasis patients according to newer classification criteria. Clin Rheumatol. 2014;33:1489–93.CrossRef

39.

Kaipiainen-Seppanen O. Incidence of psoriatic arthritis in Finland. Br J Rheumatol. 1996;35(12):1289–91.PubMedCrossRef

40.

Soderlin MK, Borjesson O, Kautiainen H, et al. Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann Rheum Dis. 2002;61(10):911–5.PubMedPubMedCentralCrossRef

41.

Savolainen E, Kaipiainen-Seppanen O, Kroger L, et al. Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 arthritis survey. J Rheumatol. 2003;30(11):2460–8.PubMed

42.

Alamanos Y, Papadopoulos NG, Voulgari PV, et al. Epidemiology of psoriatic arthritis in northwest Greece, 1982–2001. J Rheumatol. 2003;30(12):2641–4.PubMed

43.

Eder L, Chandran V, Shen H, et al. Incidence of arthritis in a prospective cohort of psoriasis patients. Arthritis Care Res (Hoboken). 2011;63:619.CrossRef

44.

Raychaudhuri SP, Farber EM. The prevalence of psoriasis in the world. J Eur Acad Dermatol Venereol. 2001;15:16–7.PubMedCrossRef

45.

Gutierrez E, Galarza C, Ramos W, et al. Skin diseases in the Peruvian Amazonia. Int J Dermatol. 2010;49:794–800.PubMedCrossRef

46.

Farber EM, Nall L. Epidemiology: natural history and genetics. In: Roenigk Jr HH, Maibach HI, editors. Psoriasis. New York: Dekker; 1998. p. 107–57.

47.

Lomholt G. Psoriasis: prevalence, spontaneous course and genetics: a census study on the prevalence of skin diseases on the Faroe Islands. GEC Gad: Copenhagen; 1963.

48.

Gudjonsson JE, Elder JT. Psoriasis: epidemiology. Clin Dermatol. 2007;25:535e46.CrossRef

49.

Olsen AO, Grjibovski A, Magnus P, et al. Psoriasis in Norway as observed in a population-based Norwegian twin panel. Br J Dermatol. 2005;153:346e51.CrossRef

50.

Schäfer T. Epidemiology of psoriasis. Review and the German perspective. Dermatology. 2006;212:327e37.

51.

Saraceno R, Mannheimer R, Chimenti S. Regional distribution of psoriasis in Italy. J Eur Acad Dermatol Venereol. 2008;22:324–9.PubMedCrossRef

52.

Wolkenstein P, Grob JJ, Bastuji-Garin S, et al. French people and skin diseases: results of a survey using a representative sample. Arch Dermatol. 2003;139:1614–9.PubMed

53.

Wolkenstein P, Revuz J, Roujeau JC, et al. Psoriasis in France and associated risk factors: results of a case–control study based on a large community survey. Dermatology. 2009;218:103–9.PubMedCrossRef

54.

Ferrándiz C, Bordas X, García-Patos V, et al. Prevalence of psoriasis in Spain (Epiderma Project: phase I). J Eur Acad Dermatol Venereol. 2001;15:20e.CrossRef

55.

Stern RS, Nijsten T, Feldman SR, et al. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc. 2004;9:136–9.PubMedCrossRef

56.

Koo J. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin. 1996;14:485–96.PubMedCrossRef

57.

Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003–2004. J Am Acad Dermatol. 2009;60:218–24.PubMedCrossRef

58.

Gelfand J, Stern R, Nijsten T, et al. The prevalence of psoriasis in African-Americans: results from a population-based study. J Am Acad Dermatol. 2005;52:23–6.PubMedCrossRef

59.

Ogunbiyi A, Daramola O, Alese O. Prevalence of skin diseases in Ibadan, Nigeria. Int J Dermatol. 2004;43:31–6.PubMedCrossRef

60.

Doe PT, Asiedu A, Acheampong JW, et al. Skin diseases in Ghana and the UK. Int J Dermatol. 2001;40:323–6.PubMedCrossRef

61.

Chandran V, Raychaudhuri S. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun. 2010;34:J314–21.PubMedCrossRef

62.

Chang Y, Chen T, Liu P, et al. Epidemiological study of psoriasis in the national health insurance database in Taiwan. Acta Derm Venereol. 2009;89:262–6.PubMedCrossRef

63.

Kaur I, Handa S, Kumar B. Natural history of psoriasis: a study from the Indian subcontinent. J Dermatol. 1997;24:230–4.PubMedCrossRef

64.

Fatani M, Abdulghani M, Al-Afif K. Psoriasis in the eastern Saudi Arabia. Saudi Med J. 2002;23:213–7.PubMed

65.

Toloza S, Vega-Hinojosa O, Chandran V, et al. Psoriasis and psoriatic arthritis in peruvian aborigines: a report from the GRAPPA 2011 annual meeting. J Rheumatol. 2012;39:2216–9.PubMedCrossRef

66.

Baker H, Golding DN, Thompson M. Psoriasis and arthritis. Ann Intern Med. 1963;58:909–25.PubMedCrossRef

67.

Rahman P, Schentag CT, Gladman DD. Excessive paternal transmission in psoriatic arhritis. Arthritis Rheum. 1999;42:1228–31.PubMedCrossRef

68.

Ogdie A. Prevalence and treatment patterns of PsA in the UK. Rheumatology. 2013;52(3):568–75.PubMedPubMedCentralCrossRef

69.

Mease P. Prevalence of rheumatologist diagnosed PsA in patients with psoriasis. J Am Acad Dermatol. 2013;69:729–35.PubMedCrossRef

70.

Roussou E, Chopra S, Ngandu DL. Phenotypic and clinical differences between Caucasian and South Asian patients with PsA living in North East London. Clin Rheumatol. 2013;32:591–9.PubMedCrossRef

71.

Marsal S, Martinez M, Armadans-Gil L, Gallado D, Ribera A, Lience E. Clinical, radiological and HLA associations as markers for different patterns of PsA. Rheumatology. 1999;38:332–7.PubMedCrossRef

72.

Queiro R, Tejon P, Coto P, Alonso S, Alperi M, Sarasqueta C, Gonzalez S, Martinez-Borra J, Lopez-Larrea C, Ballina J. Clinical differences between men and women with PsA. Clin Dev Immunol. 2013;article ID 482691:7.

73.

Li W, Han J, Qureshi AA. Smokingand the risk of incident psoriatic arthritis in US women. Ann Rheum Dis. 2012;71:804–8.PubMedPubMedCentralCrossRef

74.

Soloman DM, Love TJ, Canning C, Scheeweiss S. Risk of diabetes among patients with rheumatoid arthritis, PsA and psoriasis. Ann Rheum Dis. 2010;69:2114–7.CrossRef

75.

Miller IM, Ellervik C, Yazdanyar S, Gregor B, Jemec E. Meta-analysis of psoriasis, CVD and associated risk factors. J Am Acad Dermatol. 2013;69(6):1014–24.PubMedCrossRef

76.

Gelfand JM, Neimann AL, Shin DB. Risk of myocardial infarction inpatients with psoriasis. JAMA. 2006;296:1735–41.PubMedCrossRef

77.

Eder L, Chander V, Gladman DD. The Framingham risk score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease. Ann Rheum Dis. 2014;73:1990–6.PubMedCrossRef

Medicine Matters Rheumatology

Abstract